Review highlights olfactory testing's role in early detection of Alzheimer's in patients with mild cognitive impairment, suggesting potential for clinical applications.
Key Points
Olfactory testing identifies early signs of Alzheimer's disease in patients with mild cognitive impairment.
Significant impairment in odor identification and discrimination is observed in Alzheimer's and MCI patients.
This review analyzes clinical utility of olfactory assessment tools for effective early detection strategies.
Improvement of olfactory tests and integration with other diagnostic methods may enhance Alzheimer's intervention.